WEREWOLF THERAPEUTICS INC's ticker is HOWL and the CUSIP is 95075A107. A total of 46 filers reported holding WEREWOLF THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $97 | -26.0% | 45,200 | +5.4% | 0.00% | – |
| Q2 2023 | $131 | +47.2% | 42,900 | +25.8% | 0.00% | – |
| Q1 2023 | $89 | -44.4% | 34,100 | -56.4% | 0.00% | – |
| Q4 2022 | $160 | -99.8% | 78,223 | +327.4% | 0.00% | – |
| Q3 2022 | $83,000 | +20.3% | 18,300 | +8.9% | 0.00% | – |
| Q2 2022 | $69,000 | – | 16,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DC Funds, LP | 589,102 | $10,274,000 | 48.81% |
| MPM ASSET MANAGEMENT LLC | 4,284,172 | $74,716,000 | 13.89% |
| MPM BioImpact LLC | 2,388,011 | $41,647,000 | 6.84% |
| Soleus Capital Management, L.P. | 563,396 | $9,826,000 | 1.51% |
| RA Capital Management | 4,291,881 | $74,850,000 | 1.20% |
| SPHERA FUNDS MANAGEMENT LTD. | 706,294 | $12,049,000 | 0.82% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,552,787 | $44,521,000 | 0.79% |
| Nicholas Investment Partners, LP | 294,654 | $5,139,000 | 0.32% |
| Avidity Partners Management LP | 650,265 | $11,341,000 | 0.31% |
| PFM Health Sciences, LP | 400,000 | $6,976,000 | 0.22% |